Blog
Something inspiring would go here to explain the blog.
-
Innovative medicines as drivers of economic security – A strategic imperative for G7 economies
By
Why This Matters: Innovative medicines are engines of economic growth and security but without sustained focus and commitment to the sector, we risk losing future scientific progress. David Reddy, Director General
-
Canada’s Wait for New Medicines Is Long – and About to Get Longer
By
Why This Matters: Canada already makes patients wait too long for new medicines. Global drug policy changes could make things worse. Canadians already have the longest wait in the G7
-
Enabling Innovation: The R&D Ecosystem for Medicines and Vaccines
By
Why This Matters: A strong research and development ecosystem is essential to driving medical innovation, supporting economic growth, and ensuring Canadians can benefit from the next generation of medicines. Investment
-
Canada’s Innovation Gap: Why Your Access to Medicines is at Risk
By
Why This Matters: Canada is falling behind in providing timely access to life-saving medications, but there is a critical opportunity to build a more resilient and competitive healthcare system. Dr.
-
Nine in Ten Canadians Call for Widespread Health System Change in New Nanos Research Survey
By
Why This Matters: National polling shows thatCanadians are ready to embrace healthcare reform, calling on decision-makers for practical policy changes so proven innovations can reach Canadians faster and more equitably. A
-
Trump wants higher drug prices in Canada. That might not be bad
By
Why This Matters: Drug pricing policies can shape how quickly Canadians gain access to new medicines and future innovation. In this opinion piece from the Financial Post, Nigel Rawson and
-
Advancing made-in-B.C. health technology to strengthen patient care
By
Why This Matters: Modernizing care delivery can help improve the health system and patient access. British Columbia is helping companies pilot innovative technologies that could revolutionize healthcare delivery, support the
-
The mindset shift that could transform Canadian health care
By
Why This Matters: Protecting Canada’s health future means strengthening both patient outcomes and the economy. At a recent University of Waterloo event, former politician and executive chairman of Baylis Medical
-
Most Favored Nation Drug Pricing: Analysis and Implications
By
Why This Matters: As countries compete to attract research investment and secure early access to innovative medicines, understanding global pricing dynamics is critical to protecting Canada’s health future. This article
-
Walking a tightrope: Navigating US most-favored-nation prescription drug pricing in Canada
By
Why This Matters: As global markets adjust their drug policies, Canada faces growing competition for pharmaceutical investment and innovation. Understanding how these global drug policies interact with Canada’s domestic health